JNJ

Johnson & Johnson

Healthcare
222.89 -0.62 -0.28% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 536.54B
EV 569.48B
Shares Out 2.41B
Revenue (ttm) 96.36B
Net Income 21.04B
Beta —
P/E 25.52
Forward P/E —
EPS (ttm) $8.63
P/S 5.57
P/B 6.61
P/FCF —
P/C —
EV/Sales 5.91
EV/EBITDA —
ROA 10.47%
ROE 26.42%
ROIC —
Gross Margin 67.82%
Oper. Margin —
Profit Margin 21.83%
Debt/Eq 0.68
LT Debt/Eq 31.61%
Quick Ratio 0.69
Current Ratio 1.03
Book/sh 33.71
Cash/sh 9.0
Div Yield 2.33%
Div TTM $5.20
Payout Ratio 60.25%
SMA20 -1.94%
SMA50 -3.92%
SMA200 4.96%
Volume 5,668,958
Avg Volume 8.13M
Rel Volume —
Perf Week -3.43%
Perf Month -0.58%
Perf Quarter -9.14%
Perf Half Y 10.08%
Perf YTD 7.70%
Perf Year 45.47%
Perf 3Y 42.00%
Perf 5Y 34.30%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $1.3000
TTM Yield 2.33%
TTM Amount $5.20
Payout Ratio 60.25%
3-Yr Growth (CAGR) 4.92%
5-Yr Growth (CAGR) 5.25%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-29 $1.3000
Q4 2025 ~2025-12-28 $1.3000
Q3 2025 ~2025-09-28 $1.3000
Q2 2025 ~2025-06-29 $1.3000
Q1 2025 ~2025-03-30 $1.2400
Q4 2024 ~2024-12-29 $1.2400
Q3 2024 ~2024-09-29 $1.2400
Q2 2024 ~2024-06-30 $1.2400
Q1 2024 ~2024-03-31 $1.1900
Q4 2023 ~2023-12-31 $1.1900
Q3 2023 ~2023-10-01 $1.1900
Q2 2023 ~2023-07-02 $1.1900

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Johnson & Johnson is a leading global healthcare company engaged in the research, development, manufacture, and sale of a wide range of products in three segments: Innovative Medicine (which includes pharmaceutical products in oncology, immunology, neuroscience, cardiovascular, and other therapeutic areas), MedTech (which includes medical devices and diagnostics), and Consumer Health (which includes over-the-counter health and beauty products). The Company's diverse portfolio is designed to address significant unmet medical needs across multiple disease states and patient populations. Johnson & Johnson operates globally with a presence in numerous markets and invests substantially in research and development to drive innovation and maintain competitive advantages in the healthcare industry.

Name
Johnson & Johnson
Industry
Drug Manufacturers - General
CEO
Joaquin Duato · Chairman of the Board and Chief Executive Officer
Employees
130,000 as of 2025-12-28
IPO Date
2018-02-15
Phone
(732) 524-0400
Address
One Johnson & Johnson Plaza, New Brunswick, NJ 08933
Website
www.jnj.com

Key Executives

Name Title FY Pay
Deirdre Connelly Executive Vice President —
Peter Fasolo Executive Vice President —
James Young Executive Vice President —
Michael Ullem Vice President —
Joaquin Duato Chairman of the Board and Chief Executive Officer —

Latest News